CHST5
Basic information
Region (hg38): 16:75528530-75536108
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHST5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 20 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 6 | 3 |
Variants in CHST5
This is a list of pathogenic ClinVar variants found in the CHST5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-75529217-G-C | not specified | Uncertain significance (Jan 09, 2024) | ||
16-75529268-C-T | not specified | Likely benign (Apr 12, 2022) | ||
16-75529276-A-G | not specified | Uncertain significance (Apr 08, 2024) | ||
16-75529339-C-A | not specified | Likely benign (Nov 23, 2022) | ||
16-75529343-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
16-75529421-C-G | Benign (Nov 15, 2018) | |||
16-75529454-C-T | Benign (Nov 15, 2018) | |||
16-75529471-T-C | not specified | Uncertain significance (Apr 08, 2024) | ||
16-75529487-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
16-75529562-C-A | not specified | Uncertain significance (Dec 05, 2022) | ||
16-75529648-A-G | Rieger anomaly | Likely benign (Jan 01, 2013) | ||
16-75529652-C-T | not specified | Uncertain significance (Dec 13, 2022) | ||
16-75529700-C-T | not specified | Uncertain significance (Oct 20, 2021) | ||
16-75529722-G-T | not specified | Uncertain significance (Oct 29, 2021) | ||
16-75529745-C-T | not specified | Uncertain significance (Jun 04, 2024) | ||
16-75529898-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
16-75529910-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
16-75529912-C-G | not specified | Uncertain significance (Aug 04, 2023) | ||
16-75529936-G-T | not specified | Uncertain significance (Mar 01, 2023) | ||
16-75529954-T-C | not specified | Uncertain significance (Aug 08, 2022) | ||
16-75530041-C-T | not specified | Uncertain significance (Jan 10, 2022) | ||
16-75530063-C-G | not specified | Likely benign (Apr 07, 2022) | ||
16-75530074-T-C | not specified | Uncertain significance (Jan 04, 2024) | ||
16-75530137-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
16-75530207-C-T | not specified | Uncertain significance (May 18, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHST5 | protein_coding | protein_coding | ENST00000336257 | 1 | 6713 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000221 | 0.760 | 125639 | 0 | 66 | 125705 | 0.000263 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.351 | 286 | 303 | 0.943 | 0.0000250 | 2583 |
Missense in Polyphen | 130 | 147.46 | 0.88158 | 1275 | ||
Synonymous | 0.107 | 146 | 148 | 0.989 | 0.0000132 | 933 |
Loss of Function | 1.04 | 7 | 10.7 | 0.657 | 7.24e-7 | 82 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000704 | 0.000691 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000373 | 0.000369 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues and O-linked sugars of mucin-type acceptors. Acts on the non-reducing terminal GlcNAc of short carbohydrate substrates. However, it does not transfer sulfate to longer carbohydrate substrates that have poly-N-acetyllactosamine structures. Has no activity toward keratan. Not involved in generating HEV-expressed ligands for SELL. Its substrate specificity may be influenced by its subcellular location. {ECO:0000269|PubMed:10491328, ECO:0000269|PubMed:11352640, ECO:0000269|PubMed:12218059, ECO:0000269|PubMed:12626414}.;
- Pathway
- Metapathway biotransformation Phase I and II;Metabolism of carbohydrates;Keratan sulfate biosynthesis;Keratan sulfate/keratin metabolism;Glycosaminoglycan metabolism;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.298
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.38
Haploinsufficiency Scores
- pHI
- 0.0761
- hipred
- N
- hipred_score
- 0.238
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.235
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chst5
- Phenotype
- vision/eye phenotype;
Gene ontology
- Biological process
- carbohydrate metabolic process;N-acetylglucosamine metabolic process;protein sulfation;sulfur compound metabolic process;keratan sulfate biosynthetic process
- Cellular component
- Golgi membrane;Golgi apparatus;trans-Golgi network;integral component of membrane;intrinsic component of Golgi membrane
- Molecular function
- N-acetylglucosamine 6-O-sulfotransferase activity;sulfotransferase activity